Vaccination adverse reaction; Pain in arm; Vaccination site pain/arm pain/hurt where vaccinated; Fatigue; Depression; COVID-19 virus test positive; Loss of smell; Appetite lost; Loss of taste; General body pain; Fever; This spontaneous case was reported by a consumer and describes the occurrence of DEPRESSION (Depression), COVID-19 (COVID-19 virus test positive), VACCINATION COMPLICATION (Vaccination adverse reaction), ANOSMIA (Loss of smell) and DECREASED APPETITE (Appetite lost) in a 29-year-old male patient who received mRNA-1273 (COVID 19 Vaccine Moderna) for COVID-19 prophylaxis. The occurrence of additional non-serious events is detailed below.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) solution for injection for Ulcerative colitis.    Concurrent medical conditions included Ulcerative colitis.   On 25-Mar-2015, the patient ADALIMUMAB (HUMIRA) (Subcutaneous) dosage was changed to 40MG/0.8ML. On an unknown date, the patient received second dose of mRNA-1273 (COVID 19 Vaccine Moderna) (Intramuscular) 1 dosage form On an unknown date, received first dose of mRNA-1273 (COVID 19 Vaccine Moderna) (Intramuscular) dosage was changed to 1 dosage form. and ADALIMUMAB (HUMIRA) (Subcutaneous) at an unspecified dose every two weeks. In November 2020, the patient experienced DEPRESSION (Depression), COVID-19 (COVID-19 virus test positive), ANOSMIA (Loss of smell), DECREASED APPETITE (Appetite lost), AGEUSIA (Loss of taste), PAIN (General body pain), PYREXIA (Fever) and FATIGUE (Fatigue). In March 2021, the patient experienced VACCINATION COMPLICATION (Vaccination adverse reaction), PAIN IN EXTREMITY (Pain in arm) and VACCINATION SITE PAIN (Vaccination site pain/arm pain/hurt where vaccinated). In 2021, VACCINATION COMPLICATION (Vaccination adverse reaction), PAIN IN EXTREMITY (Pain in arm) and VACCINATION SITE PAIN (Vaccination site pain/arm pain/hurt where vaccinated) had resolved. At the time of the report, DEPRESSION (Depression) had not resolved, COVID-19 (COVID-19 virus test positive) had resolved with sequelae and ANOSMIA (Loss of smell), DECREASED APPETITE (Appetite lost), AGEUSIA (Loss of taste), PAIN (General body pain), PYREXIA (Fever) and FATIGUE (Fatigue) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In November 2020, SARS-CoV-2 test: (Positive) Positive.         No concomitant medications were reported. No treatment drugs were reported.    The reporter's causality for the event(s) of when vaccinated against covid-19, arm pain/hurt where vaccinated, positive to covid-19, fatigue, loss of smell, loss of appetite, loss of taste, generalized body pain, fever, arm pain and depression with Humira 40mg/0.4ml (Adalimumab) was no reasonable possibility. The reporter's causality for the event of REACTION to covid-19 vaccine was not provided with the Humira 40mg/0.4ml (Adalimumab).  The reporter's causality for the event(s) of when vaccinated against covid-19, arm pain/hurt where vaccinated, reaction to covid-19 vaccine, positive to covid-19, fatigue, loss of smell, loss of appetite, loss of taste, generalized body pain, fever, arm pain and depression was not provided with the Humira 40mg/0.8ml (Adalimumab).  This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.